http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1227851-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eed2c1b329fa4c3c0472f146ca907bbe
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00293
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-2817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30677
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0063
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
filingDate 2000-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a97be9596173415bb44f65c74cf2e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c5a31b3b9da7b94b3fb2c83d7817c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd204c0f1f80e0474c18457dca04a64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1639f89254dd35cc9a509b8968d986a1
publicationDate 2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1227851-A1
titleOfInvention Absorbable bone implant material and method for producing the same
abstract The invention relates to absorbable bone implant material produced from a powder component containing hydroxylapatite; and a liquid. Said powder component of the implant material essentially consists of a mixture of hydroxylapatite powder and calcium sulphate powder. The hydroxylapatite powder consists of synthetically produced, precipitated, highly pure crystalline nano-particles with a crystal size of 10-20 nm in width and 50-60 nm in length. The specific absorbent BET surface area of the nano-crystals is preferably 100-150m2/g.
priorityDate 1999-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135961720
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57112929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2201750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405857

Total number of triples: 41.